Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07612696 · ClinicalTrials.gov registry record · NA
Impact of Electronic Cigarette Temperature and Solvent on Biomarkers
A NA study, sponsored by Milton S. Hershey Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07612696: Clinical Trial NA study, sponsored by Milton S. Hershey Medical Center.
NCT07612696 is a NA study that has not yet begun recruiting, run by Milton S. Hershey Medical Center. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07612696, a NA study, has not yet begun recruiting, sponsored by Milton S. Hershey Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This project seeks to determine how e-cigarette (EC) physical design features, including those that allow the user to manipulate the quality and quantity of aerosols, affect exposure and toxicity from oxidants and other aerosol constituents.
Primary Outcome
8-isoprostane levels will be analyzed via LC-MS
Interventions
- OTHER High temperature wattage setting on electronic cigarette
- OTHER Low temperature wattage setting on electronic cigarette
- OTHER High concentration of Propylene Glycol
- OTHER Low concentration of Propylene Glycol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2028-12 |
| Phase | NA |
What is known before NCT07612696 opens enrollment
NCT07612696 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which High temperature wattage setting on electronic cigarette is the first listed.
NCT07612696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07612696 about?
NCT07612696 is a clinical study titled "Impact of Electronic Cigarette Temperature and Solvent on Biomarkers". This project seeks to determine how e-cigarette (EC) physical design features, including those that allow the user to manipulate the quality and quantity of aerosols, affect exposure and toxicity from oxidants and other aerosol constituents.
What is the current status of trial NCT07612696?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-07-15. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07612696?
The interventions under investigation include: High temperature wattage setting on electronic cigarette (OTHER), Low temperature wattage setting on electronic cigarette (OTHER), High concentration of Propylene Glycol (OTHER), Low concentration of Propylene Glycol (OTHER).
Who is sponsoring clinical trial NCT07612696?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07612696's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI